Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A usually malignant neuroendocrine tumor arising from the delta cells of the pancreas. It may be associated with inappropriate secretion of somatostatin and an associated clinical syndrome, or it may be hormonally inactive (non-functioning).
Biomarker and diagnostic research for pancreatic delta cell neuroendocrine tumor has been reported in the published literature.
No clinical trials have been registered for pancreatic delta cell neuroendocrine tumor.
51 publications have been identified in PubMed for pancreatic delta cell neuroendocrine tumor. Research spans Basic Science / Preclinical (32%), Gene Therapy / Novel Therapeutics (18%), and Diagnostic / Biomarker (12%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 16 | 32% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 5:33 PM UTC
New treatment approaches
9 |
18% |
Testing and diagnosis research | 6 | 12% |
Disease patterns and progression | 6 | 12% |
Research summaries | 5 | 10% |
Clinical study results | 4 | 8% |
Other research | 2 | 4% |
Patient case studies | 2 | 4% |
de Bont DA (2026). [PMID: 41735001](https://pubmed.ncbi.nlm.nih.gov/41735001/). *J Immunother Cancer*. [Review / Meta-Analysis]
Zabel WJ (2026). [PMID: 40928904](https://pubmed.ncbi.nlm.nih.gov/40928904/). *IEEE Trans Med Imaging*. [Gene Therapy / Novel Therapeutics]
Köylü B (2026). [PMID: 41902878](https://pubmed.ncbi.nlm.nih.gov/41902878/). *Immunotherapy*. [Case Report / Case Series]
Köse H (2026). [PMID: 41143762](https://pubmed.ncbi.nlm.nih.gov/41143762/). *Gastroenterology*. [Basic Science / Preclinical]
Yuan S (2026). [PMID: 41422437](https://pubmed.ncbi.nlm.nih.gov/41422437/). *Adv Sci (Weinh)*. [Basic Science / Preclinical]
Chawla SP (2026). [PMID: 41895777](https://pubmed.ncbi.nlm.nih.gov/41895777/). *Anticancer Res*. [Gene Therapy / Novel Therapeutics]
Alnaggar M (2026). [PMID: 41557025](https://pubmed.ncbi.nlm.nih.gov/41557025/). *J Gastrointest Cancer*. [Case Report / Case Series]
Camera S (2026). [PMID: 41758293](https://pubmed.ncbi.nlm.nih.gov/41758293/). *Target Oncol*. [Diagnostic / Biomarker]
Fraietta JA (2026). [PMID: 42103354](https://pubmed.ncbi.nlm.nih.gov/42103354/). *J Immunother Cancer*. [Gene Therapy / Novel Therapeutics]
Thummalapalli R (2025). [PMID: 41264896](https://pubmed.ncbi.nlm.nih.gov/41264896/). *JCO Precis Oncol*. [Diagnostic / Biomarker]